SCHEMBL6511702

SCHEMBL6511702

CC(C)(C)C(O)Cn1c(-c2ccccc2[N+](=O)[O-])nc2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFTR P13569 2/20 0.47
CTSD P07339 1/20 0.44
GUSB P08236 1/20 0.44
ATM Q13315 1/20 0.43
HTT P42858 2/20 0.43
CXCR3 P49682 1/20 0.41
TBXA2R P21731 1/20 0.40
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.40
MGAM O43451 1/20 0.39
MAPT P10636 2/20 0.39
AGER Q15109 1/20 0.39
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
NPY1R P25929 1/20 0.39
MAPK1 P28482 1/20 0.39
NPY2R P49146 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6513852 0.86 MGAM (0.44) CFTRHTTALDH1A1MGAMMAPT
SCHEMBL6512733 0.84 CFTR (0.49) CFTRCTSDGUSBATMHTT
SCHEMBL29412142 0.78 CFTR (0.61) CFTRCTSDGUSBKDM4EMAPT
SCHEMBL3306340 0.78 CFTR (0.61) CFTRCTSDGUSBKDM4EMAPT
SCHEMBL29411951 0.76 CFTR (0.72) CFTRALDH1A1KDM4EMAPTMEN1
SCHEMBL28381810 0.76 CFTR (0.56) CFTRCTSDGUSBHTTALDH1A1
SCHEMBL6514222 0.75 ALDH1A1 (0.59) CFTRCTSDGUSBHTTALDH1A1
SCHEMBL6514322 0.74 ALDH1A1 (0.62) CFTRHTTALDH1A1KDM4EMAPT
SCHEMBL6514788 0.74 ALDH1A1 (0.38) ALDH1A1MGAMMAPTMEN1LMNA
SCHEMBL6514897 0.73 MGAM (0.46) CFTRATMHTTALDH1A1MGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050239767-A1 Intermolecular SNAr of the heterocycle-activated nitro and fluoro groups-application in the synthesis of polyazamacrocyclic ligands NATIONAL SCIENCE FOUNDATION 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239767-A1 Intermolecular SNAr of the heterocycle-activated nitro and fluoro groups-application in the synthesis of polyazamacrocyclic ligands TECR, PAICS, DCXR CFTR 3253/4885CTSD 1262/4885GUSB 1665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.